Abstract

Metoprolol Tartrate 1.25-mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Sep/Oct 2011 - Volume 15, Number 5

Page(s): 421

Download in electronic PDF format for $75
  • Metoprolol Tartrate 1.25-mg/mL Oral Liquid Page 1

Abstract

A formulation for preparing Metoprolol Tartrate 1.25-mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • formulation
  • metoprolol tartrate
  • selective beta-1 blocker
  • hypertension
  • high blood pressure
  • angina
  • acute myocardial infarction
  • congestive heart failure

Related Categories

  • FORMULATIONS
  • CARDIOLOGY
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Sep/Oct 2011
Pg. 421
Metoprolol Tartrate 1.25-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Jul/Aug 2013
Pg. 333
Metoprolol Tartrate 1-mg/mL Injection
Author(s): Allen Loyd V Jr
Nov/Dec 2021
Pg. 503
Metoprolol Tartrate 10 mg/mL in SyrSpend SF pH4 Oral Suspension
Author(s): Allen Loyd V Jr
Mar/Apr 1997
Pg. 125-127
Quantitation of Metoprolol Tartrate and Propranolol Hydrochloride in Pharmaceutical Dosage Forms: Stability of Metoprolol in an Aqueous Mixture
Author(s): Gupta Vishnu D, Maswoswe J
May/Jun 1997
Pg. 180
Metoprolol Tartrate 10-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
May/Jun 2004
Pg. 181-185
Compounding in the Pharmacy Curriculum: Beyond the Basics
Author(s): Hinkle Amanda R, Newton Gail D
May/Jun 2006
Pg. 220
Carvedilol 1.25-mg/mL Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2009
Pg. 367-371
Congestive Heart Failure and Other Medical Facts About Ferrets; Scout's Story: A Case Report on Treating Congestive Heart Failure in a Ferret
Author(s): Williams LaVonn A, Riley Kari
May/Jun 2020
Pg. 194-197
Compounded Beta-blocker Nasal Spray for Treatment of Acute Migraine: A New Therapeutic Modality
Author(s): Hagan John C III, Everett Eric, Chamberlain Tyler
Sep/Oct 2011
Pg. 418
Carvedilol 0.625-mg/mL Oral Liquid
Author(s): Allen Loyd V Jr
Mar/Apr 2010
Pg. 108-111
Coenzyme Q10 Supplementation in the Treatment of Heart Disease
Author(s): Bramwell Bethany L
Nov/Dec 2004
Pg. 462-465
Basics of Compounding for Cough
Author(s): Allen Loyd V Jr
May/Jun 2017
Pg. 255-263
Stability of Alprazolam, Atropine Sulfate, Glutamine, Levofloxacin, Metoprolol Tartrate, Nitrofurantoin, Ondansetron Hydrochloride, Oxandrolone, Pregabaline, and Riboflavin in SyrSpend SF pH4 Oral Suspensions
Author(s): de Oliveira Ferreira Anderson, Polonini Hudson C, Loures da Silva Sharlene, Cerqueira de Melo Victor Augusto, de Andrade Laura, Fernandes Brandão Marcos Antônio
May/Jun 2018
Pg. 233
Atenolol 1 mg/mL or 5 mg/mL in SyrSpend SF pH4
Author(s): Allen Loyd V Jr
Jul/Aug 2021
Pg. 327
Nifedipine 4.mg/mL in SyrSpend SF pH4 Cherry Flavored
Author(s): Allen Loyd V Jr
Sep/Oct 2006
Pg. 386
Lisinopril 1-mg/mL, Sodium Citrate, and Citric Acid Oral Liquid
Author(s): Allen Loyd V Jr
Jan/Feb 2015
Pg. 60
Atenolol 25-, 50-, or 100-mg Capsules
Author(s): Allen Loyd V Jr
Mar/Apr 2019
Pg. 148
Captopril 0.8 mg/mL in SyrSpend SF Oral Suspension
Author(s): Allen Loyd V Jr
Sep/Oct 2012
Pg. 419
Enalaprilat 1.25-mg/mL Injection
Author(s): Allen Loyd V Jr
Sep/Oct 2019
Pg. 412
Valsartan 4 mg/mL in Vehicle for Oral Solution USP
Author(s): Allen Loyd V Jr